Kyverna Therapeutics shares owned by Goldman Sachs Group
Quarter-by-quarter ownership of Kyverna Therapeutics (KYTX) shares owned by Goldman Sachs Group
from 13F filings
Historical chart of Goldman Sachs Group investment in Kyverna Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Kyverna Therapeutics held by Goldman Sachs Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Kyverna Therapeutics by Goldman Sachs Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $259k | 43k | 6.00 |
| 2025-03-31 | $202k | 105k | 1.93 |
| 2024-12-31 | $424k | 114k | 3.74 |
| 2024-09-30 | $390k | 80k | 4.89 |
| 2024-06-30 | $467k | 62k | 7.50 |